Senior insider sale
SVP, Research and Development at ARTIVA BIOTHERAPEUTICS, INC. — senior position signals high conviction
$32.3K
3.50K shares
What this filing means
RAYMON HEATHER plans to sell 3.50K shares of ARTIVA BIOTHERAPEUTICS, INC. valued at approximately $32.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/18/2026ACC: 0002028466-26-000003
Officer· SVP, Research and Development
Since Feb 2026
3.50K
Shares to sell
$32.3K
Approx. market value
3.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units vesting under registered plan
Compensation for services rendered to Issuer
5/15/2026
3.50KTotal acquired3.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Units vesting under registered plan Compensation for services rendered to Issuer | 3.50K | — |
| Total | 3.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.50K
Market value
$32.3K
5/18/2026
Total
Units
3.50K
Value
$32.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/18/2026 | 3.50K | $32.3K | NASDAQ | Planned |
| Total | 3.50K | $32.3K | ||